Clinical Trial

Impact of Combined Oral Contraceptive Pills on Migraine

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 9, 2024 (before its estimated May 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators will assess the effect of combined oral contraceptive pills (COCs) on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal contraceptive use on migraineurs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-13.
Trial Details
NCT Number NCT06509503
Lead Sponsor Kafrelsheikh University
Conditions Migraine
Enrollment 400 participants
Start Date 2024-07-15
Primary Completion 2025-05-15 (estimated)
Study Completion 2025-07-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-09